Bioethics Council: Gene-Editing Human Embryos Conditionally OK

The UK-based organization encourages public debate about the issue but does not recommend immediate policy change.

Written byShawna Williams
| 1 min read
an embryo on a white background
Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The Nuffield Council on Bioethics, an influential, independent body in the U.K. that provides recommendations on medical and biological questions, released a report today (July 17) suggesting that gene-editing of human embryos should be permissible in some circumstances. UK law currently prohibits making alterations to people that could be passed down to future generations, and the report stops short of recommending an immediate change to that policy, but instead encourages public debate around what regulations should be in place.

“It is our view that genome editing is not morally unacceptable in itself,” Karen Yeung, chair of the working group behind the report and a professor of law, ethics, and informatics at the University of Birmingham, tells The Guardian. “There is no reason to rule it out in principle.”

The working group recommends that changing embryos’ genes should only be permitted when the intervention would benefit the future child, and when ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Shawna was an editor at The Scientist from 2017 through 2022. She holds a bachelor’s degree in biochemistry from Colorado College and a graduate certificate in science communication from the University of California, Santa Cruz. Previously, she worked as a freelance editor and writer, and in the communications offices of several academic research institutions. As news director, Shawna assigned and edited news, opinion, and in-depth feature articles for the website on all aspects of the life sciences. She is based in central Washington State, and is a member of the Northwest Science Writers Association and the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies